World Bank approves $500 million for Turkey for COVID-19 vaccines

[May 27, 2022]  ISTANBUL (Reuters) - The World Bank said on Thursday that its board had approved $500 million in additional financing to support Turkey in its efforts to fight against COVID-19.

The funds, which will have a maturity of 10.5 years with a five-year grace period, will be used to ensure access to safe and effective COVID-19 vaccines in Turkey, the bank said.

An additional $250 million will be provided as co-financing from the Asian Infrastructure and Investment Bank (AIIB), the bank said, adding that the project aims to help meet the cost vaccine purchases.

"This project will allow the Government to refocus its financial capacities on activities and reforms that may have been adversely affected during the pandemic," Task Leader Nadwa Rafeh said in the press release.

A man leaves after receiving a dose of Turkey's domestically-produced Turkovac coronavirus disease (COVID-19) vaccine at the Ankara City Hospital in Ankara, Turkey January 6, 2022. REUTERS/Cagla Gurdogan

The World Bank had previously approved $100 million in funds for Turkey in April 2020.

(Reporting by Can Sezer; Writing by Ali Kucukgocmen; Editing by Daren Butler)
 

[© 2022 Thomson Reuters. All rights reserved.] 

This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content.